Research Article

Interpretation of Controversial Teratogenic Findings of Drugs Such As Phenobarbital

Table 2

Results of multivariate matched analysis for each case with different CAs and its all (1–3) matched controls using conditional logistic regression model to estimate the adjusted odds ratio (OR) with 95% confidence interval (CI) of oral phenobarbital treatment during the entire pregnancy and the second and/or third gestational months.

Study groupsGrand totalSecond and third monthsEntire pregnancy
no.no.%Adjusted OR*95% CIno.%Adjusted OR*95% CI

Isolated CAs
 Neural-tube defects1,20240.33.90.6–23.4110.92.30.8–6.1
 Cleft lip ± palate1,37460.42.30.7–7.9120.91.80.8–4.3
 Posterior cleft palate58220.330.51.20.3–5.5
 Intestinal atresia/stenosis15310.721.33.90.3–46.1
 Obstructive urinary CAs27100.020.7
 Hypospadias3,038130.42.30.9–5.4311.02.61.44.8
 Undescended testis2,05160.31.00.3–2.7160.81.70.8–3.4
 Congenital hydrocephaly31410.31.40.1–24.920.60.80.1–5.2
 Ear CAs35400.030.94.50.4–46.2
 Cardiovascular CAs4,47940.10.30.1–0.9160.40.70.4–1.3
 Clubfoot2,42440.21.90.5–7.9100.41.00.4–2.3
 Limb deficiencies54830.60.80.2–3.340.70.90.2–3.3
 Poly/syndactyly1,74480.52.60.9–7.6120.71.50.7–3.4
 Diaphragmatic CAs24300.041.72.30.5–9.6
 Other isolated CAs2,71760.20.90.3–2.490.30.50.2–1.1
Multiple CAs1,34950.42.50.6–9.8120.91.60.7–3.5

Total case group22,843630.31.30.9–1.91490.71.31.11.7

Total control group38,151920.2Reference2090.6Reference

Matched OR adjusted for maternal age, birth order, maternal employment status, and high fever-related maternal diseases.
Bold numbers show significant associations.